Literature DB >> 15897451

VEGF-integrin interplay controls tumor growth and vascularization.

Sarmishtha De1, Olga Razorenova, Noel Patrick McCabe, Timothy O'Toole, Jun Qin, Tatiana V Byzova.   

Abstract

Cross-talk between the major angiogenic growth factor, VEGF, and integrin cell adhesion receptors has emerged recently as a critical factor in the regulation of angiogenesis and tumor development. However, the molecular mechanisms and consequences of this intercommunication remain unclear. Here, we define a mechanism whereby integrin alpha v beta3, through activation, clustering, and signaling by means of p66 Shc (Src homology 2 domain containing), regulates the production of VEGF in tumor cells expressing this integrin. Tumors with "activatable" but not "inactive" beta3 integrin secrete high levels of VEGF, which in turn promotes extensive neovascularization and augments tumor growth in vivo. This stimulation of VEGF expression depends upon the ability of alpha v beta3 integrin to cluster and promote phosphorylation of p66 Shc. These observations identify a link between beta3 integrins and VEGF in tumor growth and angiogenesis and, therefore, may influence anti-integrin as well as anti-VEGF therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15897451      PMCID: PMC1129024          DOI: 10.1073/pnas.0502935102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  A mechanism for modulation of cellular responses to VEGF: activation of the integrins.

Authors:  T V Byzova; C K Goldman; N Pampori; K A Thomas; A Bett; S J Shattil; E F Plow
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

Review 2.  The role of alpha(v)beta(3) in prostate cancer progression.

Authors:  Carlton R Cooper; Christopher H Chay; Kenneth J Pienta
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

Review 3.  Role of integrins in cell invasion and migration.

Authors:  John D Hood; David A Cheresh
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

4.  Elevated levels of p66 Shc are found in breast cancer cell lines and primary tumors with high metastatic potential.

Authors:  J G Jackson; T Yoneda; G M Clark; D Yee
Journal:  Clin Cancer Res       Date:  2000-03       Impact factor: 12.531

5.  Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins.

Authors:  Louise E Reynolds; Lorenza Wyder; Julie C Lively; Daniela Taverna; Stephen D Robinson; Xiaozhu Huang; Dean Sheppard; Richard O Hynes; Kairbaan M Hodivala-Dilke
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

Review 6.  Beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling.

Authors:  D R Phillips; L Nannizzi-Alaimo; K S Prasad
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

7.  Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice.

Authors:  Andrew R Reynolds; Louise E Reynolds; Tobi E Nagel; Julie C Lively; Stephen D Robinson; Daniel J Hicklin; Sarah C Bodary; Kairbaan M Hodivala-Dilke
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

8.  Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.

Authors:  Niels Reinmuth; Wenbiao Liu; Syed A Ahmad; Fan Fan; Oliver Stoeltzing; Alexander A Parikh; Corazon D Bucana; Gary E Gallick; Maureen A Nickols; William F Westlin; Lee M Ellis
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

9.  Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells.

Authors:  Melanie Rolli; Emilia Fransvea; Jan Pilch; Alan Saven; Brunhilde Felding-Habermann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-21       Impact factor: 11.205

Review 10.  Role of angiogenesis in tumor growth and metastasis.

Authors:  Judah Folkman
Journal:  Semin Oncol       Date:  2002-12       Impact factor: 4.929

View more
  67 in total

1.  VEGF-induced vascular permeability is mediated by FAK.

Authors:  Xiao Lei Chen; Ju-Ock Nam; Christine Jean; Christine Lawson; Colin T Walsh; Erik Goka; Ssang-Taek Lim; Alok Tomar; Isabelle Tancioni; Sean Uryu; Jun-Lin Guan; Lisette M Acevedo; Sara M Weis; David A Cheresh; David D Schlaepfer
Journal:  Dev Cell       Date:  2012-01-17       Impact factor: 12.270

2.  Vascular endothelial growth factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin {alpha}9{beta}1: identification of a specific {alpha}9{beta}1 binding site.

Authors:  Saji Oommen; Shiv K Gupta; Nicholas E Vlahakis
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

3.  Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

Authors:  Xianzhong Zhang; Zhengming Xiong; Yun Wu; Weibo Cai; Jeffery R Tseng; Sanjiv S Gambhir; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2006-01       Impact factor: 10.057

Review 4.  Extracellular matrix: The driving force of mammalian diseases.

Authors:  Renato V Iozzo; Maria A Gubbiotti
Journal:  Matrix Biol       Date:  2018-04-03       Impact factor: 11.583

5.  Antagonistic VEGF variants engineered to simultaneously bind to and inhibit VEGFR2 and alphavbeta3 integrin.

Authors:  Niv Papo; Adam P Silverman; Jennifer L Lahti; Jennifer R Cochran
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

6.  Cilengitide affects tumor compartment, vascularization and microenvironment in experimental bone metastases as shown by longitudinal ¹⁸F-FDG PET and gene expression analysis.

Authors:  Maren Bretschi; Caixia Cheng; Hendrik Witt; Antonia Dimitrakopoulou-Strauss; Ludwig G Strauss; Wolfhard Semmler; Tobias Bäuerle
Journal:  J Cancer Res Clin Oncol       Date:  2012-12-11       Impact factor: 4.553

7.  New applications of nanotechnology for neuroimaging.

Authors:  G Suffredini; J E East; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-28       Impact factor: 3.825

8.  Protein-crystal interface mediates cell adhesion and proangiogenic secretion.

Authors:  Fei Wu; Weisi Chen; Brian Gillis; Claudia Fischbach; Lara A Estroff; Delphine Gourdon
Journal:  Biomaterials       Date:  2016-11-25       Impact factor: 12.479

9.  Maternal administration of anti-angiogenic agents, TNP-470 and Angiostatin4.5, induces fetal microphthalmia.

Authors:  Catrin S Rutland; Keyi Jiang; Gerald A Soff; Christopher A Mitchell
Journal:  Mol Vis       Date:  2009-06-26       Impact factor: 2.367

10.  An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression.

Authors:  Jay S Desgrosellier; Leo A Barnes; David J Shields; Miller Huang; Steven K Lau; Nicolas Prévost; David Tarin; Sanford J Shattil; David A Cheresh
Journal:  Nat Med       Date:  2009-09-06       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.